Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

European shares struggle ahead of speeches from ECB policymakers

(Reuters) -European shares dipped on Monday following a string of weekly losses, weighed down by real estate and technology stocks, while investors awaited speeches from European Central Bank policymakers to gauge the path of interest rates.

The continent-wide STOXX 600 index dropped 0.2% by 0909 GMT.

The benchmark posted its first four-week losing streak in 2-1/2 years on Friday, hit by disappointing earnings, a jump in Treasury yields and concerns about the impact of U.S. President-elect Donald Trump’s policies on global economies and businesses.

European tech shares dipped 0.6% ahead of AI bellwether Nvidia (NASDAQ:NVDA)’s quarterly results on Wednesday. Most major sectors were lower, with real estate stocks leading declines.

Investors awaited speeches from ECB chief economist Philip Lane and President Christine Lagarde later in the day as well as euro zone November flash PMIs on Friday for clues on the path of interest rates.

“We think this week’s PMI readings are unlikely to fully reflect recent political highlights and should therefore not be expected to stray far from the most recent, subdued readings,” Unicredit (BIT:CRDI) analysts said in a note.

ECB Vice President Luis de Guindos said global trade tensions further the risk for an already weak euro zone economy. Another policymaker, Joachim Nagel, said the tariffs promised by Trump would upend international trade but may ultimately have a “minor impact” on inflation.

Traders are pricing in a 72% chance of a 25 bps rate cut by the ECB in December, and see cuts of 142 bps by the end of next year.

Britain’s Melrose (LON:MRON) Industries rose 8.6% after the owner of aerospace parts maker GKN (LON:GKN) Aerospace reported a 7% rise in revenue for the four-month period ended Oct. 31.

Dutch technology investor Prosus (OTC:PROSF) climbed 1.3% after its trading statement.

Grifols (BME:GRLS) fell 2.8% after news website El Confidencial reported Canadian fund Brookfield planned to offer about 7 billion euros ($7.4 billion) for the Spanish drugmaker.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com